Relationality and Ethics in MDMA-Assisted Therapy.
Jamie Beachy, Willa Hall, Chantelle Thomas, Ingmar Gorman, Kelley C. O’donnell
The American Journal of Bioethics January 13, 2025 DOI: 10.1080/15265161.2024.2433445 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Commentary or response article Peer reviewed |
|---|---|
| Intervention | MDMA-assisted therapy |
| Topics | MDMA |
| Citations | 2 |
| Key points | Argues that the critique of MDMA-assisted therapy for PTSD misrepresents its safety and efficacy, and that the therapy is a promising option for treatment-resistant PTSD. |
Abstract
As research therapists with hundreds of hours of clinical experience supporting adults with PTSD in Phase 3 trials of MDMA assisted-therapy (MAT), we appreciate the opportunity to respond to this s...
Citations in the library
Cites 7
- MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine June 1, 2021
- MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial. Nature Medicine October 1, 2023
- Studying Harms Is Key to Improving Psychedelic-Assisted Therapy—Participants Call for Changes to Research Landscape JAMA Psychiatry March 29, 2023
- Distinctive But Not Exceptional: The Risks of Psychedelic Ethical Exceptionalism. The American Journal of Bioethics 2025
- Wolves Among Sheep: Sexual Violations in Psychedelic-Assisted Therapy. The American Journal of Bioethics January 13, 2025
and 2 more in the library